SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $266,579 | -23.3% | 76,824 | +2.8% | 0.00% | – |
| Q2 2023 | $347,397 | +4.6% | 74,709 | +4.2% | 0.00% | – |
| Q1 2023 | $332,000 | +21785.3% | 71,669 | -61.8% | 0.00% | – |
| Q4 2022 | $1,517 | -99.8% | 187,778 | +20.7% | 0.00% | – |
| Q3 2022 | $864,000 | +6.0% | 155,577 | -0.5% | 0.00% | – |
| Q2 2022 | $815,000 | -41.9% | 156,431 | -8.4% | 0.00% | – |
| Q1 2022 | $1,403,000 | +67.8% | 170,766 | +204.1% | 0.00% | – |
| Q4 2021 | $836,000 | -21.9% | 56,156 | -1.0% | 0.00% | – |
| Q3 2021 | $1,071,000 | -8.8% | 56,719 | -10.2% | 0.00% | – |
| Q2 2021 | $1,174,000 | -12.7% | 63,148 | +6.9% | 0.00% | – |
| Q1 2021 | $1,345,000 | -7.0% | 59,087 | -11.3% | 0.00% | – |
| Q4 2020 | $1,447,000 | +94.2% | 66,597 | -8.0% | 0.00% | – |
| Q3 2020 | $745,000 | +16.4% | 72,412 | -12.2% | 0.00% | – |
| Q2 2020 | $640,000 | -38.3% | 82,472 | -19.0% | 0.00% | – |
| Q1 2020 | $1,038,000 | -8.8% | 101,873 | -1.5% | 0.00% | – |
| Q4 2019 | $1,138,000 | +27.0% | 103,418 | +4.9% | 0.00% | – |
| Q3 2019 | $896,000 | -16.9% | 98,542 | +3.7% | 0.00% | – |
| Q2 2019 | $1,078,000 | -1.3% | 95,039 | -0.9% | 0.00% | – |
| Q1 2019 | $1,092,000 | +21.6% | 95,860 | -3.6% | 0.00% | – |
| Q4 2018 | $898,000 | -40.2% | 99,451 | -0.6% | 0.00% | – |
| Q3 2018 | $1,501,000 | – | 100,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |